Company seeks approval for skin cancer drug

December 15, 2014 1:09 PM

3 0

Company seeks approval for skin cancer drug

A Roche Holding AG subsidiary submitted a drug for treating people treating patients with an advanced form of skin cancer to U.S. regulators, the company said Monday, starting the process for potential approval of the therapy.

Genentech, Roche’s U.S.-based biotechnology subsidiary, said it had submitted a new drug application for its cobimetinib treatment to be used in combination with the existing Zelboraf treatment for patients with mutation-positive advanced melanoma.

Read more

To category page

Loading...